Washington – Now soon a mere blood test would be just sufficient to know if post-menopausal hormone therapies there a high risk of a heart attack, says the recent researches.
The latest research is a part of the Women’s Health Initiative (WHI) and incorporated 271 cases of coronary heart disease (CHD) from forty centers nation-wide in the 1st 4 years of the trials of estrogen alone and of estrogen plus progestin.
“Because studies on hormone therapy have shown that they may increase heart attacks and strokes, many women have been unwilling to use this treatment,” said Paul F. Bray, M.D
He also added: “However, because hormones remain the most effective remedy for managing post-menopausal symptoms, such as hot flashes and night sweats, many women wanted to take this therapy, but have struggled with the decision because they feared the potential side effects. We found that a simple and widely used blood test may be useful to advise women if they are at an increased risk of a heart attack while undergoing hormone therapy.”
As per the findings, those who go into the research with positive cholesterol levels were less susceptible to a raised risk of developing heart problems while taking hormones (estrogen alone or estrogen plus progestin), as match up to to women with adverse cholesterol levels.
Predominantly, women with ratios of “bad” cholesterol to “good” cholesterol less than 2.5 did not come into view to be at a raised heart disease danger when using hormone therapy, while those with higher ratios of “bad” to “good” cholesterol were known to be at higher risk of coronary heart disease (CHD). In addition, this study shows that risk is manifolds if they go for take hormone therapy.
“This report only considered the effects of hormone therapy on coronary disease outcomes. Instead of genetic testing or another more complicated test, we wanted to find a simple and effective way to assess the heart risk of hormone therapy,” said Bray.
The researches are accounted in the newest edition of the American Journal of Cardiology.